Jim Cramer on Intuitive Surgical: “Too Much Competition”

Jim Cramer on Intuitive Surgical: “Too Much Competition” Syeda Seirut Javed Tue, June 23, 2026 at 4:31 PM GMT+2 1 min read ISRG JNJ MDT Intuitive Surgical, Inc. (NASDAQ: ISRG ) was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down . Inquiring about the stock, a caller asked if it is a buy.

Cramer replied: Too much competition, too much competition… Used to be king, used to be king. Now, there's a lot of kings. There's like three kings or maybe even four kings, and that's the problem because there's too many kings.

Photo by Adam Nowakowski on Unsplash Intuitive Surgical, Inc. (NASDAQ:ISRG) designs and manufactures robotic systems and instruments that enable minimally invasive surgical and diagnostic procedures. A caller asked about the stock during the April 30 episode, and Cramer commented: Here's the thing: Both J&J and Medtronic claim they've got competitors.

And I am worried that one of those two is going to hit pay dirt, and that is going to hurt Intuitive Surgical. While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years   Disclosure: None. Follow Insider Monkey on Google News .